Loading ...

human somatostatin receptor subtype-2 agonist octreotate-conjugated Cy5.5/crosslinked dextran-modified iron oxide nanoparticles

Based on

1 Articles
2014 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

Cy5.5/crosslinked dextran-modified iron oxide nanoparticles

Cy5.5-SPIO
Type Nano Material
Formula
Role core
2

human somatostatin receptor subtype-2 agonist octreotate

hSSTr2 agonist octreotate
Type Biomolecule
Formula
Role layer

Applications

Area Application Nanomaterial Variant Source
diagnostics

More information available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
nude mice bearing both C6 glioma expressing hSSTr<sub>2</sub> and C6 wild-type glioma without hSSTr2 expression

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
  1. 4DI
  2. 1UZ
  3. HeG3
Product

human somatostatin receptor subtype-2 agonist octreotate-conjugated Cy5.5/crosslinked dextran-modified iron oxide nanoparticles

Size: not specified

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial